Daily Stock Analysis, DXD, DEXCOM INC, priceseries

DEXCOM INC. Daily Stock Analysis
Stock Information
Open
23.96
Close
23.90
High
24.10
Low
23.90
Previous Close
23.94
Daily Price Gain
-0.04
YTD High
37.07
YTD High Date
Jan 3, 2019
YTD Low
23.88
YTD Low Date
Nov 13, 2019
YTD Price Change
-11.09
YTD Gain
-31.69%
52 Week High
40.71
52 Week High Date
Dec 26, 2018
52 Week Low
23.88
52 Week Low Date
Nov 13, 2019
52 Week Price Change
-6.61
52 Week Gain
-21.66%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 4. 2018
30.84
Dec 27. 2018
35.97
15 Trading Days
16.64%
Link
Company Information
Stock Symbol
DXD
Exchange
NASDAQ
Company URL
http://www.dexcom.com
Company Phone
8582000200
CEO
Kevin Ronald Sayer
Headquarters
California
Business Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA 92121
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001093557
About

Description

DexCom, Inc., a medical device company, together with its subsidiaries, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its products include DexCom G4 PLATINUM system for continuous use by adults with diabetes; DexCom G4 PLATINUM with Share, a remote monitoring system; and DexCom G5 Mobile, a CGM system that directly communicates to a patient's mobile and its data can be integrated with DexCom CLARITY, which is a next generation cloud-based reporting software for personalized, easy-to-understand analysis of trends to improve diabetes management. The company also offers sensor augmented insulin pumps. It has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. The company was founded in 1999 and is headquartered in San Diego, California.